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Abstract
Purpose The English NHS has mandated the routine collec-
tion of health-related quality of life (HRQoL) data before and
after surgery, giving prospective patient information about the
likely benefit of surgery. Yet, the information is difficult to
access and interpret because it is not presented in a lay-
friendly format and does not reflect patients’ individual cir-
cumstances. We set out a methodology to generate person-
alised information to help patients make informed decisions.
Methods We used anonymised, pre- and postoperative
EuroQol-5D-3L (EQ-5D) data for over 490,000 English
NHS patients who underwent primary hip or knee replace-
ment surgery or groin hernia repair between April 2009 and
March 2016.We estimated linear regressionmodels to relate
changes in EQ-5D utility scores to patients’ own assessment
of the success of surgery, and calculated from that minimally
important differences for health improvements/deteriora-
tions. Classification tree analysis was used to develop algo-
rithms that sort patients into homogeneous groups that best
predict postoperative EQ-5D utility scores.
Results Patients were classified into between 55 (hip
replacement) to 60 (hernia repair) homogeneous groups.
The classifications explained between 14 and 27% of
variation in postoperative EQ-5D utility score.
Conclusions Patients are heterogeneous in their expected
benefit from surgery, and decision aids should reflect this.
Large administrative datasets on HRQoL can be used to
generate the required individualised predictions to inform
patients.
Introduction
‘‘But will this treatment help me?’’ This simple question
reflects one of the most commonly voiced concerns in
many consultations with a doctor. Patients facing surgery
have always wanted to know about the risks they face and
whether treatment will be effective. Nowadays patients
increasingly want to be actively engaged in the (co-)man-
agement of their medical condition, including the choice of
treatment. To be able to participate in shared decision-
making (SDM) patients require information on the relative
effectiveness of alternative treatment options. But the
effectiveness of medical treatments is often moderated by
patient characteristics, such as age, gender, co-morbidity
burden or genetic factors [17]. Hence, for information to be
most relevant for the specific SDM context, it needs to
reflect patients’ personal circumstances closely [1].
Randomised controlled trials, which are seen as the gold
standard in effectiveness research, assess the average
effectiveness across the study population. This information
is, of course, most useful to prospective patients who share
the same characteristics of the average person enrolled in
the trial. But patients enrolled in trials tend to be system-
atically different from those to whom treatment will be
given in routine practice and, of course, all patients are
different. In recognition of this, there is rapidly growing
literature on risk stratification and the concept of person-
alised medicine [2, 15, 25, 26]. The aim is to distinguish
different groups of patients according to their observable
pre-treatment characteristics so as to derive personalised
predictions of their expected outcomes that are, ceteris
paribus, more targeted than those based on experiences of
the average patient who has previously had the treatment.
However, these developments have not yet found their way
into many popular decision aids used in routine clinical
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practice. In part, this may reflect the lack of sufficiently
large medical studies that allow for fine-grained subgroup
analysis. Even those trials that are powered for subgroup
analysis tend to focus only on a limited number of single-
factor contrasts. They are not, therefore, suitable for gen-
erating detailed risk profiles.
The emergence of large, routinely collected longitudinal
datasets on patients’ health-related quality of life (HRQoL)
opens up the possibility to move away from exclusive
focus on average experience and to develop detailed risk
stratification models. Since April 2009, the English NHS
has mandated the routine collection of patient-reported
outcome measures (PROMs) from all NHS-funded patients
undergoing planned hip or knee replacement, varicose vein
surgery or groin hernia repair. Patients are asked to report
their health status and HRQoL using the EuroQol-5D-3L
(EQ-5D-3L) and condition-specific instruments before and
some months after surgery. By March 2015, over 800,000
patients had participated in these surveys and reported pre-
and postoperative health measures. These data can be used
for the purpose of risk stratification.
The aim of this paper is to report on the development
of an online patient information tool (http://www.after
mysurgery.org.uk) and the underlying algorithm that uti-
lise this large amount of HRQoL data to generate
personalised (i.e. risk stratified) predictions. This tool is
designed to be used by patients in consultation with their
primary care physicians and general practitioners (GPs) in
discussions about the likely benefits of surgery. The for-
mat of the tool draws on recent literature on the most
suitable presentational format of HRQoL data to inform
patients and medical professionals. In what follows, we
describe the data and the analytical approach to risk
stratification. We then describe how the tool has been
developed and piloted, and provide examples of its pre-
sentational form. We conclude by outlining the next steps
in its development and rollout for use to inform SDM
between patients and their doctors.
Methods
Data
We utilise individual-level EQ-5D-3L data on all NHS-
funded patients in England aged 15 or over who underwent
planned unilateral hip or knee replacement or groin hernia
repair between April 2009 and March 2016 [5].1 Patients
are invited to report their HRQoL using paper-based
questionnaires at two time points: at the time of admission
or in the preceding outpatient appointment, and then again
three months after surgery (6 months for orthopaedic pro-
cedures); see [10] for full details on data collection. These
data are anonymised and made publicly available by the
Health & Social Care Information Centre (HSCIC) (http://
www.hscic.gov.uk/proms) and form the basis of our risk
stratification algorithm. Patients were excluded if they
underwent revision surgery or if relevant data items were
missing (complete case analysis). Data released prior to the
financial year 2012/2013 did not distinguish between pri-
mary and revision joint surgery. We therefore obtained
individual-level EQ-5D-3L data linked to administrative
hospital records (Hospital Episode Statistics) for these
financial years to reconstruct the necessary revision flag
from OPCS 4.6 procedure codes [5] and then applied the
HSCIC anonymization rules.
The EQ-5D-3L measures health-related quality of life
along five health dimensions [3]: mobility, self-care, usual
activities, pain and discomfort, and anxiety and depression.
On each dimension, patients can indicate whether they
have no, some or extreme problems. The resulting health
profiles are summarised using utility weights obtained
from members of the general public in England [6],
anchored at 1 (full health) and 0 (dead), with scores\0
indicating states worse than being dead. In addition, the
dataset contains information on patients’ age (in 10-year
bands), sex, self-reported duration of symptoms, and self-
reported co-morbid diagnoses (high blood pressure, stroke,
diabetes, poor circulation, depression, arthritis, cancer and
diseases of the lung, liver, heart, kidneys, or the nervous
system). Furthermore, patients indicated their overall
assessment of the outcome of surgery on a five-point scale
(‘Overall, how are your [hip/knee/hernia] problems now,
compared to before the operation?’ with answers ‘much
better’, ‘a little better’, ‘about the same’, ‘a little worse’,
‘much worse’).
No ethical approval was required for analysis of anon-
ymised secondary data.
Risk stratification
The aim of our empirical analysis was to generate algo-
rithms to allocate prospective patients to strata or groups of
similar expected postoperative utility scores. We employed
non-parametric data mining techniques to populate sepa-
rate regression trees for each of the treatments [17, 30]. The
trees were generated through a recursive Classification and
Regression Tree (CART) algorithm that split the
dataset along risk variables to generate nodes and then
repeated this process for each resulting tree branch until the
1 We did not include varicose vein patients since the number of
complete data points is substantially lower and a large number of
patients report pre-operative EQ-5D-3L health profiles as 11111, i.e.
there is no capacity to improve.
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dataset could not be split further or the overall fit of the
model could no longer be improved. The resulting tree
branches represent conjunctions of patient characteristics,
and each branch ends in a strata allocation (‘leaf’). Patients
within a strata have similar expected outcomes, but their
realised outcomes may differ due to random variation or
unmeasured determinants. This uncertainty is reflected in
the distribution of observed outcomes within a strata.
Our candidate set of split variables included all pre-
operative patient characteristics available in the dataset.
However, after discussions with GP stakeholders and
patients, it was decided that a limit on the number of
variables needed to be imposed so that the tool could be
used within a typical 10-minute doctor consultation.
Exploratory analysis revealed that only few self-reported
comorbidities led to branch splits and only in few
instances. The final set of risk variables thus included
only age, gender, pre-operative EQ-5D-3L profile and
symptom duration, this limited set offering a balance
between parsimony and explanatory power. Patients
reporting health profiles of 11111 or 33333 prior to
surgery were analysed separately and subsequently added
to the classification algorithm. Patients in these pre-op-
erative health states cannot improve/deteriorate but, due
to the low frequency, may have been included erro-
neously within other groups had they not been analysed
separately. This would otherwise have created logical
inconsistencies in the presentation of results (see below)
for these patients.
All analyses were performed in R3.2.1 using the CART
package. The advantage of CART analysis over a more
traditional regression analysis lies in the way the former
handles interactions between variables and non-linearities.
By considering all possible variable splits and orderings,
and only retaining the model that fits the data best, CART
identifies all relevant interactions and can easily incorpo-
rate non-linear effects of continuous or categorical vari-
ables. However, this data-driven modelling approach may
lead to overfitting and poor predictive ability in indepen-
dent samples. Overfitting occurs if ‘‘idiosyncracies in the
data are fitted rather than generalizable patterns’’ ([28], p.
5). Since the structure of the statistical model is uncertain,
the flexibility granted to the CART algorithm can result in
a statistical model (here: grouping) that fits the data at
hand but is less informative or potentially misleading to
future users. To explore this, we used all data up until
March 2015 (development sample) to estimate the
regression trees and then calculated the model fit in terms
of adjusted R2 and root mean squared error (RMSE) in a
sample of patients treated between April 2015 and March
2016 (test sample), where we include indicator variables
for each of the strata.
Presentation
For the information presented in the online tool to be useful
to patients and their GPs, it needs to be easily inter-
pretable and meaningful and not overburden the recipient
with detail [11, 23]. A large literature has explored how
best to communicate information to patients, and a recent
series of studies focussed on patients’ and doctors’ pref-
erences for and ability to interpret different presentational
formats of hospital performance information based on
HRQoL data [12–14]. Many of their findings apply to
presentation of HRQoL data more broadly and have
informed this work.
Content
An important conceptual choice in the development of our
patient information tool has been between focussing on
either the change in HRQoL as a result of treatment or the
postoperative level of HRQoL. Both approaches have merit
and convey important information. Patients are naturally
interested in whether treatment improves their HRQoL
given their individual starting points, i.e. whether treatment
is effective. At the same time, understanding the absolute
level of health they are likely to achieve may facilitate
comprehending the potential benefits in terms of patients’
ability to participate in everyday life, and may also lead to
more realistic expectations. Treatment may well improve
their HRQoL but not restore them to a level that they
regard as sufficient to warrant surgery (and associated
risks). For the purpose of this patient information tool, both
types of information are therefore presented.
Metrics
A closely related question is then how to make these data
meaningful to the recipients. PROM scores are unfamiliar
to patients (and often doctors as well) and ‘‘unlike mea-
sures of height or weight, [. . .] their values have no
immediate meaning. It’s therefore necessary to transform
them into interpretable forms, or indeed into experiences
rather than metrics, to make them useful’’ ([14], p. 11).
For measures of change one metric that has been
advocated is the ‘minimally important difference’ (MID).
The MID can be derived in a number of ways. We followed
the anchor-based methodology employed recently by [4] to
obtain MIDs for our study sample.2 The MID for
improvements is calculated as the difference in EQ-5D
utility change score between all patients that reported their
problems as ‘a little better’ and those that report their
2 In doing so, we generated an update to their MID estimates
obtained from a much smaller sample.
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problems as ‘about the same’. The MID for deteriorations
is calculated in a similar way. Different MIDs are calcu-
lated for each of the three procedures. We then calculate
the proportion of patients in each strata that have notice-
ably improved, did not experience a noticeable change, or
have noticeably deteriorated.
For postoperative levels, we report the proportions of
patients reporting no/some/extreme problems by EQ-5D
dimension.
Format
Concerns have been voiced about patients’ ability to
interpret numeric information and different presentational
formats. Pictographic presentation of data is generally well
understood and accepted and has been advocated for risk
communication [8, 12, 24, 29]. Percentage points were
shown as 100 stylised human figures. We colour those in
traffic light colours to indicate improvement (green), no
change (yellow), and deterioration (red), and similarly for
postoperative problems (no/some/extreme).
To abstract from the concept of probability, we intro-
duce each graph with the text ‘‘This is how 100 patients like
you felt after surgery’’. This phrase helps patients to put the
presented amounts into context and also emphasises the
aspect of risk stratification. Proportions were rounded so
that they always sum to 1 (100%). Results are presented in
terms of overall impact on health and for each of the EQ-
5D dimensions.
Results
Risk stratification
Our development sample consisted of 497,723 patients
with complete pre- and postoperative EQ-5D-3L health
profiles and no missing information on any of the relevant
risk variables.3 The descriptive statistics for the develop-
ment sample are reported in Table 1. For all three treat-
ments, the patient populations’ pre-operative HRQoL
spanned more than 160 EQ-5D-3L health profiles, thereby
covering a large proportion of the 243 (=35) possible EQ-
5D-3L health profiles. This variability facilitates the iden-
tification of interaction effects between health dimensions.
For comparison, a representative sample (n = 7294) of the
general population in England reported 98 unique EQ-5D-
3L health profiles [7], and participants in a multi-country
instrument validation study drawn from eight patient
groups and a student cohort (n = 3919) described their
HRQoL using 124 unique EQ-5D-3L health profiles [16].
Despite the wide coverage, the distribution of health pro-
files in our sample is highly concentrated, as is observed in
other studies using the EQ-5D-3L [7]. More than 90% of
patients in each of the three treatment groups could be
described by no more than 17 profiles.
The regression trees classified patients into 55 (hip
replacement), 59 (knee replacement) and 60 (groin hernia
repair) distinct groups (Table 2). Figure 1 shows as an
example the tree structure for hip replacement surgery. The
groups in each tree were well populated, with median
group sizes of 1732 (IQR=674–6182) for hip replacement,
1269 (IQR=474–4337) for knee replacement, and 564
(IQR=240–2018) for groin hernia repair. These groups
explained 14–27% of the variance in postoperative EQ-5D
utility scores in the development sample, with similar,
albeit slightly attenuated performance in the test sample.
Conversely, a model based on age, sex and symptom per-
iod (‘reduced model’) explains no more than 2% of the
variance.
The MIDs for improvements/deteriorations are reported
in Table 3. MIDs for hip and knee replacement are similar
in magnitude. Improvements need to be larger to be
noticeable to patients than deteriorations, i.e. the MIDs are
not symmetric. Estimates for groin hernia repair are sub-
stantially different.
Figure 2 illustrates the importance of risk stratification
for the purposes of classifying hip replacement patients
according to their probability of improving, deteriorating or
not experiencing any noticeable change in their HRQoL.
Each stacked horizontal bar represents these probabilities
for one of the 55 risk groups. There is marked variation in
predicted outcomes across groups, with twelve groups
(n = 52,850 patients) showing\70% risk of improvement
and thirteen groups (n = 39,883) showing C95% risk of
improvement (based on rounded numbers). It is also
instructive to compare these to a prediction for the average
patient in the sample as would often be presented in
existing decision aids. The average patient has an 81% risk
of improvement (and a 3% risk of deterioration)(see
Table 1). Only two groups, representing a total of
n = 12,076 patients, have a predicted risk of improvement
of ±5% around this average. Hence, for the vast majority
of patients, information about the average risk of
improvement would likely be misleading.
Online tool user interface
Figure 3 gives examples of the feedback that patients
receive after having provided information on their pre-
operative HRQoL, age, gender and symptom period.
3 In some cases, missing information was collected but not released
by the HSCIC as part of their publicly available dataset to ensure that
patients cannot be re-identified. See also FN2.
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Table 1 Descriptive statistics of development sample
Hip replacement (N = 185,111) Knee replacement (N = 198,007) Groin hernia repair (N = 114,605)
Age groups (n, %)
15–29 328 0.2% 12 0.0% 2426 2.1%
30–39 1139 0.6% 146 0.1% 4803 4.2%
40–49 6022 3.3% 2319 1.2% 12,191 10.6%
50–59 24,579 13.3% 21,765 11.0% 20,660 18.0%
60–69 62,871 34.0% 72,153 36.4% 36,618 32.0%
70–79 67,079 36.2% 76,997 38.9% 28,280 24.7%
80–89 22,419 12.1% 24,169 12.2% 9287 8.1%
C90 674 0.4% 446 0.2% 340 0.3%
Gender (n, %)
Female 109,892 59.4% 112,019 56.6% 6230 5.4%
Male 75,219 40.6% 85,988 43.4% 108,375 94.6%
Symptomperiod (n, %)
\1 year 25,831 14.0% 9,863 5.0% 74,896 65.4%
1–5 years 127,008 68.6% 103,841 52.4% 39,709 34.6%
6–10 years 20,386 11.0% 43,308 21.9%
[10 years 11,886 6.4% 40,995 20.7%
Pre-operative EQ–5D
Utility score (mean, SD) 0.356 0.319 0.414 0.309 0.791 0.196
Profile—MO (n, %)
1 12,299 6.6% 13,553 6.8% 92,640 80.8%
2 172,278 93.1% 184,053 93.0% 21,907 19.1%
3 534 0.3% 401 0.2% 58 0.1%
Profile— SC (n, %)
1 84,533 45.7% 138,356 69.9% 110,629 96.5%
2 98,739 53.3% 58,391 29.5% 3815 3.3%
3 1839 1.0% 1260 0.6% 161 0.1%
Profile—UA (n, %)
1 11,054 6.0% 18,467 9.3% 83,597 72.9%
2 140,344 75.8% 155,240 78.4% 28,829 25.2%
3 33,713 18.2% 24,300 12.3% 2179 1.9%
Profile—PD (n, %)
1 1,275 0.7% 1,837 0.9% 37,014 32.3%
2 106,670 57.6% 120,539 60.9% 72,975 63.7%
3 77,166 41.7% 75,631 38.2% 4616 4.0%
Profile—AD (n, %)
1 109,184 59.0% 125,807 63.5% 97,287 84.9%
2 67,642 36.5% 65,184 32.9% 16,296 14.2%
3 8285 4.5% 7016 3.5% 1022 0.9%
Postoperative EQ–5D
Utility score (mean, SD) 0.785 0.246 0.724 0.257 0.876 0.189
Patients’ overall assessment of outcome (n, %)
Improved 149,127 80.6% 141,273 71.3% 54,767 47.8%
No change 29,775 16.1% 44,420 22.4% 43,771 38.2%
Deteriorated 6209 3.4% 12,314 6.2% 16,067 14.0%
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Patients will first be presented with information on the
proportion of patients achieving a minimally important
difference. They can then request detailed information on
the predicted postoperative HRQoL in a similar format,
print the results, or amend the information they provided.
In all cases, patients are urged to discuss the results with
their GP before making a decision. They are also
reminded that the results are based on a snapshot of their
HRQoL on that day and may therefore change over time
as their HRQoL (or the reporting thereof) changes.
Table 2 Predictive
performance of risk
stratification algorithm
Procedure #groups Development sample Test sample Reduced model
adjR2 RMSE adjR2 RMSE adjR2 RMSE
Hip replacement 55 14.3% 0.228 12.8% 0.218 1.5% 0.244
Knee replacement 59 19.4% 0.231 18.8% 0.224 2.1% 0.255
Groin hernia repair 60 27.0% 0.161 28.1% 0.158 1.3% 0.188
Development sample: April 2009 to March 2015. Test sample: April 2015 to March 2016. Reduced model
only considers age, sex and symptom period for grouping and is estimated and tested on the development
sample. R2 is adjusted for number of predictor variables, i.e. groups
CART − Hip replacement
Q1_ANXIETY >= 1.5
Q1_SELF_CARE >= 1.5
Q1_ANXIETY >= 2.5
AGE < 55
Q1_ACTIVITY >= 2.5
Q1_SYMPTOMPERIOD >= 2.5
Q1_SYMPTOMPERIOD >= 2.5
Q1_ACTIVITY >= 2.5
Q1_SELF_CARE >= 2.5
Q1_SYMPTOMPERIOD >= 1.5
Q1_ACTIVITY >= 2.5
Q1_DISCOMFORT >= 2.5
Q1_ACTIVITY >= 2.5
Q1_SELF_CARE >= 2.5
Q1_SYMPTOMPERIOD >= 2.5
AGE < 55
Q1_SYMPTOMPERIOD >= 1.5
Q1_SYMPTOMPERIOD >= 2.5
Q1_SYMPTOMPERIOD >= 1.5
Q1_ACTIVITY >= 2.5
AGE >= 75
MALE < 0.5
AGE >= 75
Q1_DISCOMFORT >= 2.5
Q1_ANXIETY >= 2.5
Q1_ACTIVITY >= 2.5
Q1_MOBILITY >= 1.5
Q1_ANXIETY >= 2.5
AGE >= 65
Q1_SELF_CARE >= 1.5
Q1_DISCOMFORT >= 2.5
Q1_ACTIVITY >= 2.5
Q1_SELF_CARE >= 2.5
Q1_SYMPTOMPERIOD >= 2.5
Q1_SYMPTOMPERIOD >= 1.5
Q1_SYMPTOMPERIOD >= 2.5
AGE >= 75
MALE < 0.5
AGE >= 75
Q1_ACTIVITY >= 2.5
Q1_ACTIVITY >= 2.5
MALE < 0.5
AGE >= 65
Q1_DISCOMFORT >= 2.5
AGE >= 65
Q1_MOBILITY >= 1.5
AGE >= 65
MALE < 0.5
Q1_ACTIVITY >= 2.5
AGE >= 75
MALE < 0.5
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Fig. 1 Regression tree for hip replacement. Branches for pre-operative EQ-5D health profiles 11111 and 33333 not shown
Table 3 Estimates of
minimally important differences
(MIDs)
Procedure MID - Improvement MID - Deterioration
Est 95% CI Est 95% CI
Hip replacement 0.106 (0.095–0.116) -0.091 (-0.075 to -0.106)
Knee replacement 0.090 (0.083–0.097) -0.081 (-0.071 to -0.090)
Groin hernia repair 0.041 (0.033–0.048) -0.069 (-0.056 to -0.081)
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The online tool has been designed following best
practice for maximising accessibility. It has been tested
by local GPs in York (United Kingdom), members of the
Vale of York Clinical Commissioning Group, a patient
representative and a prospective patient, and two vision
impaired members of staff. This process led to changes
in wording and colour scheme, and a reduction in the
number of patient characteristics considered for risk
stratification (see Section 2.2). The overall feedback
indicates that the webtool is easy to use and that the
presentational format aids understanding of the informa-
tion provided.
Discussion
Informing prospective patients about the likely outcomes
of treatment as part of SDM can help shape realistic
expectations, improve satisfaction with treatment choices
and outcomes, reduce decision uncertainty and may reduce
demand for major invasive surgery [27]. But the informa-
tion that most doctors can relay is limited to the average
outcome experienced by patients in clinical trials. For
many patients, this will be an inaccurate or even mislead-
ing reflection of their likely outcome, either because the
clinical trials did not sample similar patients or because
their personal characteristics and, hence, likely outcomes
are substantially different from the average person enrolled
in the trial.
There is an increasing policy push towards routine col-
lection of PROM data to improve healthcare delivery in a
number of health systems including Sweden, Australia,
Canada, the Netherlands, the USA and the UK. The advent
of large-scale data collection of the experiences of patients
treated in routine practice makes it possible to develop risk
stratification algorithms and provide patients with infor-
mation that more closely reflects their individual circum-
stances. But this information needs to be presented in an
accessible and understandable fashion in order to support
SDM between patients and doctors. In this paper, we have
demonstrated a method for presenting information about
the effectiveness of treatment according to the specific
characteristics of prospective patients, rather than in terms
merely of average effects. We have also shown how the
information can be made available to patients and doctors
in an interactive format to help support SDM.
The multidimensional nature of HRQoL presents some
unique challenges in developing a patient information tool.
Prospective patients are likely to differ in the amount of
information they can process effectively. Some patients
will prefer a simple summary of the likely outcomes they
may experience such as the MID. Others may wish to see
predictions by HRQoL. To ensure that the underlying
stratification is consistent across both presentational for-
mats, we decided to group patients according to their
postoperative EQ-5D utility scores and then translate that
information into MIDs but also allow retrieval of the
underlying EQ-5D health profiles. There is some evidence
that the relationship between patient characteristics and
outcome differs by EQ-5D dimension [9], so that dimen-
sion-specific stratification algorithms might generate dif-
ferent, more accurate, groupings than that developed on
EQ-5D utility scores. McCarthy [19, 20] has recently
suggested a two-step approach to combine separate treat-
ment effect estimates by EQ-5D domain into a composite
effect. It may be possible to extend this methodology to
0 20 40 60 80 100
Percent
Got worse No change Improved
Fig. 2 Differences in proportion of hip replacement patients report-
ing significant improvements, deteriorations or no change across 55
risk strata (nodes)
Fig. 3 Screenshots of the user interface
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risk stratification, something that might merit further
exploration.
Our current stratification algorithms explain from 14%
(hip replacement) to 27% (hernia repair) of variation in
EQ-5D utility scores three or six months after surgery. A
similar algorithm developed to predict EQ-5D utility scores
in a large Swedish hip replacement population one year
after surgery was able to explain 17% of variation [21].
Performance may be enhanced by stratifying on a larger
number of patient characteristics, although these gains in
explanatory power need to be balanced against reduced
usability during time-constraint GP consultations, as more
time would be required to complete the interface entry.
Perfect explanatory power is an unrealistic ambition, with a
substantial part of the variation in HRQoL likely to remain
unexplained because it either originates from random sta-
tistical variation or reflects patient characteristics that are
impossible to observe prior to surgery such as the patient’s
future adherence to the postoperative recovery plan [28].
Even with limited explanatory power, prospective patients
will still benefit from receiving tailored predictions instead
of information on average outcomes.
There are a number of ways in which this work can be
taken forward. The current version of the online tool is
informative only about the outcome of surgery but does not
provide information on what would have happened in its
absence, i.e. under watchful waiting or other forms of
treatment. We are aware of some local initiatives to collect
such data in Gloucestershire, UK and Alberta, Canada.
These initiatives offer the prospect of providing informa-
tion about alternative courses of treatment so that, in future,
patients can be informed by comparative assessments.
A second issue arises from the use of patient-reported
data to stratify risk groups. These data are likely to vary
over measurement occasions, and so, for example, a patient
may report some pain and discomfort on Monday and
extreme levels on Tuesday. This implies that the infor-
mation presented is conditional on how they are feeling at
the time and, consequently, their predicted outcomes may
vary as well. There are two solutions. One is to collect self-
assessed HRQoL longitudinally to better isolate true level
of HRQoL from random variation. The other is to ignore
self-assessed data and use only objective data (such as age
and gender), but this comes at the expense of explanatory
power.
Finally, personalised medicine can be understood to
involve not only risk stratification but also approaches to
incorporating preference heterogeneity amongst patients
[26]. We currently base all calculations on EQ-5D index
scores derived using the MVH-A1 tariff [6]. But value sets
are not neutral and the choice of valuations has important
effects on the distribution of EQ-5D index scores and any
inferences based upon them [22]. Previous research has
shown that value sets derived from specific patient popu-
lations differ systematically from those derived from the
general population [18], and it is likely that even within
patient groups, there exists substantial heterogeneity in
preferences. However, eliciting preferences from individ-
ual patients, as sometimes done in SDM, would also
require deriving individual measures of MIDs to fit with
our current presentational format and this may be difficult
for patients to determine prior to surgery.
In conclusion, we believe that large administrative
PROM datasets offer the opportunity to derive individu-
alised predictions of the likely outcome of treatment,
thereby helping patients to make better decisions, generate
more realistic expectations about treatment outcomes, and
increase satisfaction with treatment.
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